GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Beneish M-Score

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Beneish M-Score : -2.99 (As of May. 03, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.99 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ExpreS2ion Biotech Holding AB's Beneish M-Score or its related term are showing as below:

OSTO:EXPRS2' s Beneish M-Score Range Over the Past 10 Years
Min: -6.09   Med: -2.93   Max: 214.75
Current: -2.99

During the past 10 years, the highest Beneish M-Score of ExpreS2ion Biotech Holding AB was 214.75. The lowest was -6.09. And the median was -2.93.


ExpreS2ion Biotech Holding AB Beneish M-Score Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Beneish M-Score Chart

ExpreS2ion Biotech Holding AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.86 -4.23 -6.09 -2.03 214.75

ExpreS2ion Biotech Holding AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.76 214.75 9.99 -0.89 -2.99

Competitive Comparison of ExpreS2ion Biotech Holding AB's Beneish M-Score

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ExpreS2ion Biotech Holding AB's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's Beneish M-Score falls into.



ExpreS2ion Biotech Holding AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ExpreS2ion Biotech Holding AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.3405+0.528 * 0.9669+0.404 * 1.6386+0.892 * 0.9203+0.115 * 1.457
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.013363-0.327 * 1.7115
=-2.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Total Receivables was kr2.69 Mil.
Revenue was 1.454 + 1.921 + 2.566 + 0.972 = kr6.91 Mil.
Gross Profit was 0.663 + 0.937 + 1.222 + -0.358 = kr2.46 Mil.
Total Current Assets was kr95.37 Mil.
Total Assets was kr101.92 Mil.
Property, Plant and Equipment(Net PPE) was kr2.10 Mil.
Depreciation, Depletion and Amortization(DDA) was kr1.46 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr19.09 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Net Income was -21.826 + -30.038 + -26.308 + -48.533 = kr-126.71 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0.00 Mil.
Cash Flow from Operations was -12.277 + -34.106 + -39.528 + -39.432 = kr-125.34 Mil.
Total Receivables was kr8.60 Mil.
Revenue was 0.833 + 1.248 + 2.033 + 3.398 = kr7.51 Mil.
Gross Profit was -0.82 + 0.099 + 1.084 + 2.226 = kr2.59 Mil.
Total Current Assets was kr165.11 Mil.
Total Assets was kr170.50 Mil.
Property, Plant and Equipment(Net PPE) was kr0.85 Mil.
Depreciation, Depletion and Amortization(DDA) was kr1.26 Mil.
Selling, General, & Admin. Expense(SGA) was kr10.05 Mil.
Total Current Liabilities was kr18.66 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2.694 / 6.913) / (8.598 / 7.512)
=0.389701 / 1.144569
=0.3405

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2.589 / 7.512) / (2.464 / 6.913)
=0.344649 / 0.35643
=0.9669

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (95.372 + 2.102) / 101.92) / (1 - (165.109 + 0.85) / 170.498)
=0.043622 / 0.026622
=1.6386

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6.913 / 7.512
=0.9203

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.264 / (1.264 + 0.85)) / (1.463 / (1.463 + 2.102))
=0.597919 / 0.410379
=1.457

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 6.913) / (10.045 / 7.512)
=0 / 1.337194
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 19.086) / 101.92) / ((0 + 18.655) / 170.498)
=0.187265 / 0.109415
=1.7115

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-126.705 - 0 - -125.343) / 101.92
=-0.013363

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ExpreS2ion Biotech Holding AB has a M-score of -2.99 suggests that the company is unlikely to be a manipulator.


ExpreS2ion Biotech Holding AB Beneish M-Score Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Traded in Other Exchanges
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines